Small-cap value has long been a favored hunting ground for investors seeking higher expected returns through deeper discounts and factor exposure. AVUV and VIOV sit squarely in this niche, but they arrive at similar goals through very different paths. AVUV is an actively managed fund from Avantis Investors that selects stocks based on value and profitability criteria, while VIOV is a passive Vanguard product tied to the S&P SmallCap 600 Value Index. Comparing the two offers a practical case study in active versus index-driven factor investing, making this ETF comparison especially relevant for investors weighing cost, diversification, and the consistency of their sector exposure.
AVUV is an actively managed exchange-traded fund that invests primarily in U.S. small-capitalization companies exhibiting low valuations and strong profitability characteristics. Rather than tracking an index, the portfolio team applies a systematic approach that emphasizes stocks with higher expected returns based on adjusted book-to-price ratios and cash-based profitability metrics. The fund typically holds between roughly 775 and 800 securities, keeping position sizes small and diversification broad. Top holdings have recently included MATX, GATX, SM, M, LNTH, and VSAT, each representing roughly 1% or less of assets. Sector allocation leans heavily toward financials (around 27%), consumer cyclicals (near 19%), and energy (roughly 15%), with a more modest weight in technology. The fund charges a 0.25% expense ratio and, since its 2019 launch, has grown into one of the larger and most liquid small-cap value ETFs on the market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
VIOV is a passively managed fund that seeks to track the performance of the S&P SmallCap 600 Value Index, which measures the value segment of the broader S&P SmallCap 600 universe. Under normal conditions, the fund invests at least 80% of its assets in the stocks that make up the target index, using a market-capitalization-weighted, rules-based methodology. VIOV holds approximately 465 securities, with top positions recently including MOH, MTCH, EMN, KMX, and JXN, each generally below 1.3% of assets. Sector exposure is led by financial services (around 20%), consumer cyclicals (about 15%), technology (near 14%), and industrials (roughly 12%), with a more meaningful presence in real estate and healthcare than AVUV. VIOV charges a low 0.10% expense ratio and was launched in 2010, offering a lower-cost, more index-pure vehicle within the small-cap value category.
Both ETFs operate within the U.S. small-cap value segment, a space that has drawn renewed attention amid shifting interest rate expectations and a rotation away from mega-cap growth leadership. Smaller companies are generally more sensitive to domestic economic conditions, borrowing costs, and credit availability, which means relative positioning within this segment can swing meaningfully across market cycles. Value-oriented sectors such as financials, energy, and industrials have been influenced by recent themes including bank capital dynamics, commodity price trends, and reshoring of manufacturing capacity. Regulatory and macroeconomic factors, such as the trajectory of Federal Reserve policy and lending conditions for smaller firms, remain central risks. The divergence between AVUV's deeper value and profitability tilt and VIOV's broader, index-based construction highlights how different methodologies can capture these themes with varying intensity.
Across recent weeks and months, the two funds have generally moved in tandem as small-cap value peers, but their underlying differences have produced distinct positioning. AVUV's heavier weight in energy and financials, coupled with its emphasis on cheaper, more profitable names, has historically amplified both upside and downside relative to the broader small-cap value benchmark. VIOV, with its higher technology and real estate allocation and its rules-based rebalancing, has tended to display a somewhat smoother, more index-like profile. In environments where commodity prices firm and value spreads widen, AVUV's deeper factor exposure has often been a tailwind, while VIOV's lower cost and broader sector mix may offer more consistent alignment with the benchmark. Investors evaluating fund performance should weigh these structural differences in volatility and factor loading against their own objectives for relative positioning.
When comparing funds like these, I often turn to Tickeron's AI Screener to quickly scan for comparable small-cap value holdings and assess technical patterns or fundamental metrics across the category. It lets me apply filters for industry exposure, volatility, and performance trends in a single workflow, which helps surface nuances that might otherwise require hours of manual review. This kind of data-driven check adds context without replacing the core analysis of expense ratios, sector weights, and methodology.
Based on observable structural characteristics, Tickeron's AI would likely favor AVUV for investors seeking a deeper, more concentrated value and profitability exposure with strong trend consistency in its heaviest sectors. AVUV's systematic, profitability-enhanced selection process and its pronounced financials and energy tilt position it to potentially capture more of the factor premium when value outperforms. However, for cost-conscious investors prioritizing benchmark fidelity and lower fees, VIOV's 0.10% expense ratio and broader sector diversification make it a highly competitive alternative. The AI's preference is probabilistic rather than definitive: AVUV appears better suited to those accepting active risk for deeper factor exposure, while VIOV remains a compelling, lower-cost option for disciplined index investors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
VIOV saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 82 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VIOV's RSI Oscillator exited the oversold zone, 26 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for VIOV just turned positive on October 05, 2026. Looking at past instances where VIOV's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
Following a +0.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIOV advanced for three days, in 240 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
VIOV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VIOV entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallValue